Neoteryx has been acquired by Trajan Group Holdings

Neoteryx, LLC has been sold to Trajan Group Holdings Limited.

Neoteryx, based in Southern California, is a global leader in blood micro-sampling, with operations in the USA and Europe. Its customers include scientific researchers, laboratories and health providers working to advance telemedicine, pharmaceutical development, biotechnology research and clinical diagnostics.

Trajan Group Holdings is a global developer and manufacturer of analytical and life sciences products and devices used in the analysis of biological, food, water and other environmental samples. The company has more than 520 employees, operating across the USA, Australia, Europe and Malaysia.

One of Oaklins’ teams in the USA served as the exclusive financial advisor to Neoteryx, LLC in this transaction.

SERVICIO

M&A sell-side

PARTES

“At Neoteryx we developed innovative technology to transform specimen collection, and our goal was to achieve global commercial scale through a strategic transaction. The Oaklins team brought deep industry expertise and relationships to this assignment and a sharp focus on achieving our objectives. Our partnership with Trajan is an exciting outcome for the Neoteryx team and our customers as we together leverage micro-sampling to create advanced healthcare solutions.”

Fasha Mahjoor

Founder and CEO, Neoteryx, LLC

Contáctese con el equipo de la transacción

Michael S. Goldman

Director General

Nueva York, Estados Unidos
Oaklins TM Capital

Ver perfil Contáctenos

James McLaren

Director General

Nueva York, Estados Unidos
Oaklins TM Capital

Ver perfil Contáctenos

John Dean

Director Asociado

Atlanta, Estados Unidos
Oaklins TM Capital

Ver perfil Contáctenos

Transacciones relacionadas

CARSO Group has acquired a majority stake in AQCF Group

Private Equity | Servicios de Soporte Comercial | Salud

CARSO Group has acquired a majority stake in AQCF Group

CARSO Group, a leading provider of testing services, has acquired a majority stake in AQCF Group, a key player in the field of food safety.

Prestige Inhome Care has found a long-term strategic partner

Salud

Prestige Inhome Care has found a long-term strategic partner

Prestige Inhome Care has received a growth capital investment from Yorkway Private. The newly formed partnership will provide growth capital for geographic expansion, increasing Prestige’s range of services and potential future acquisitions. The investment in Prestige is in line with Yorkway’s mandate to invest in leading Australian mid-market companies with strong management teams, backed by significant growth tail winds, as is the case in the aged care industry.

Cara Care has been acquired by Mahana Therapeutics

Private Equity | Salud | TMT

Cara Care has been acquired by Mahana Therapeutics

Mahana Therapeutics Inc., renowned for its pioneering digital treatments targeting chronic health issues, has recently finalized the acquisition of Cara Care (HiDoc Technologies GmbH). Cara Care stands out as a premier digital health platform and an official digital health application (DiGA) dedicated to enhancing gut health. This acquisition, supported by key investors Lux Capital and Jazz Ventures Partners, perfectly aligns with Mahana’s expansion strategy.